In addition, Hong et al. also found a positive link between the expression level of BTLA and that of TIGIT in renal cell carcinoma, showing the potential to be considered as a pair of targets in the immunotherapy for the tumor [54]. The gene discussed is TIGIT; the disease is renal cell carcinoma.